WA
GOSS icon

Waddell & Associates’s Gossamer Bio GOSS Stock Holding History

Waddell & Associates’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
3,272
+2,428
+288% +$54.2K ﹤0.01% 540
2026
Q1 		$22.2K Buy
+844
New +$106K ﹤0.01% 447

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Waddell & Associates's GOSS Position: Q2 2026 in Review

Waddell & Associates increased its Gossamer Bio (GOSS) stake by 288% in Q2 2026, buying an estimated $54.2K and bringing the position to 3,272 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Waddell & Associates first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Waddell & Associates held 3,272 shares of Gossamer Bio worth $43.1K as of Q2 2026.
  • Waddell & Associates bought 2,428 Gossamer Bio shares in Q2 2026, an estimated $54.2K.
  • Gossamer Bio made up ﹤0.01% of Waddell & Associates's portfolio in Q2 2026, its #540 holding.
  • Waddell & Associates first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.